polymorphprep tm (Progen Biotechnik)
Structured Review
Polymorphprep Tm, supplied by Progen Biotechnik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polymorphprep+tm/polymorphprep/pmc11501092-70-16-18
Average 90 stars, based on 1 article reviews
Images
Related Articles
Isolation:Article Title: Functional classification of antineutrophil cytoplasmic antibody (ANCA) and its relation with clinical parameters of ANCA-associated vasculitis Article Snippet: .. Neutrophils were isolated from the peripheral blood of healthy volunteers using Article Title: Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels. Article Snippet: Aims: Advanced glycation end products (AGEs), particularly AGE-modified albumin (AGE-BSA), have been implicated in vascular inflammation and endothelial dysfunction, while neutrophil extracellular traps (NETs) are known to aggravate endothelial injury.. Here, we investigated whether AGE-BSA directly promotes endothelial inflammatory and thrombotic activation, modulates neutrophil oxidative stress and NET formation, and may enhance NET-induced endothelial inflammation.. Materials, methods, and key findings: In human aortic and human umbilical vein endothelial cells, two different endotoxin-free AGE-BSA formulations did not or only minimally alter the expression or secretion of inflammatory (IL-6, IL-1β, CCL2) or thrombotic (VCAM-1, tissue factor) markers. Article Title: Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers. Article Snippet: .. We isolated human peripheral blood mononuclear cells (PBMCs) from whole blood samples of healthy donors by density gradient centrifugation using Gradient Centrifugation:Article Title: Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels. Article Snippet: Aims: Advanced glycation end products (AGEs), particularly AGE-modified albumin (AGE-BSA), have been implicated in vascular inflammation and endothelial dysfunction, while neutrophil extracellular traps (NETs) are known to aggravate endothelial injury.. Here, we investigated whether AGE-BSA directly promotes endothelial inflammatory and thrombotic activation, modulates neutrophil oxidative stress and NET formation, and may enhance NET-induced endothelial inflammation.. Materials, methods, and key findings: In human aortic and human umbilical vein endothelial cells, two different endotoxin-free AGE-BSA formulations did not or only minimally alter the expression or secretion of inflammatory (IL-6, IL-1β, CCL2) or thrombotic (VCAM-1, tissue factor) markers. Article Title: Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers. Article Snippet: .. We isolated human peripheral blood mononuclear cells (PBMCs) from whole blood samples of healthy donors by density gradient centrifugation using |
